Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunotherapy-related adverse effects on 18F-FDG PET/CT imaging.
Gandy N, Arshad MA, Wallitt KL, Dubash S, Khan S, Barwick TD. Gandy N, et al. Among authors: arshad ma. Br J Radiol. 2020 Jul;93(1111):20190832. doi: 10.1259/bjr.20190832. Epub 2020 Feb 27. Br J Radiol. 2020. PMID: 32105505 Free PMC article.
What's New in Imaging for Gynecologic Cancer?
Khan SR, Arshad M, Wallitt K, Stewart V, Bharwani N, Barwick TD. Khan SR, et al. Curr Oncol Rep. 2017 Nov 6;19(12):85. doi: 10.1007/s11912-017-0640-3. Curr Oncol Rep. 2017. PMID: 29105030 Review.
FDG-PET Imaging in Cervical Cancer.
Gandy N, Arshad MA, Park WE, Rockall AG, Barwick TD. Gandy N, et al. Among authors: arshad ma. Semin Nucl Med. 2019 Nov;49(6):461-470. doi: 10.1053/j.semnuclmed.2019.06.007. Epub 2019 Jun 24. Semin Nucl Med. 2019. PMID: 31630730 Review.
[18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer.
Sharma R, Valls PO, Inglese M, Dubash S, Chen M, Gabra H, Montes A, Challapalli A, Arshad M, Tharakan G, Chambers E, Cole T, Lozano-Kuehne JP, Barwick TD, Aboagye EO. Sharma R, et al. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1239-1251. doi: 10.1007/s00259-019-04532-z. Epub 2019 Nov 21. Eur J Nucl Med Mol Imaging. 2020. PMID: 31754793 Free PMC article. Clinical Trial.
Spatial heterogeneity of radiolabeled choline positron emission tomography in tumors of patients with non-small cell lung cancer: first-in-patient evaluation of [18F]fluoromethyl-(1,2-2H4)-choline.
Dubash S, Inglese M, Mauri F, Kozlowski K, Trivedi P, Arshad M, Challapalli A, Barwick T, Al-Nahhas A, Stanbridge R, Lewanski C, Berry M, Bowen F, Aboagye EO. Dubash S, et al. Theranostics. 2020 Jul 9;10(19):8677-8690. doi: 10.7150/thno.47298. eCollection 2020. Theranostics. 2020. PMID: 32754271 Free PMC article.
Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients.
Arshad MA, Thornton A, Lu H, Tam H, Wallitt K, Rodgers N, Scarsbrook A, McDermott G, Cook GJ, Landau D, Chua S, O'Connor R, Dickson J, Power DA, Barwick TD, Rockall A, Aboagye EO. Arshad MA, et al. Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):455-466. doi: 10.1007/s00259-018-4139-4. Epub 2018 Sep 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 30173391 Free PMC article.
Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography.
Arshad MA, Gitau S, Tam H, Park WE, Patel NH, Rockall A, Aboagye EO, Bharwani N, Barwick TD. Arshad MA, et al. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2009-2023. doi: 10.1007/s00259-020-05136-8. Epub 2020 Dec 11. Eur J Nucl Med Mol Imaging. 2021. PMID: 33313962 Free PMC article.
72 results